Cited 0 times in Scipus Cited Count

Biomarkers of Glycosaminoglycans (GAG) accumulation in patients with mucopolysaccharidosis type VI—LeukoGAG, Corneal Opacification (COM) and Carotid Intima Media Thickening (CIMT)

DC Field Value Language
dc.contributor.authorSohn, YB-
dc.contributor.authorWang, R-
dc.contributor.authorAshworth, J-
dc.contributor.authorBroqua, P-
dc.contributor.authorTallandier, M-
dc.contributor.authorAbitbol, JL-
dc.contributor.authorJozwiak, E-
dc.contributor.authorPollard, L-
dc.contributor.authorWood, TC-
dc.contributor.authorAslam, T-
dc.contributor.authorHarmatz, PR-
dc.date.accessioned2024-02-13T23:27:13Z-
dc.date.available2024-02-13T23:27:13Z-
dc.date.issued2024-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/32220-
dc.description.abstractMucopolysaccharidosis type VI (MPS VI) is an autosomal recessive lysosomal storage disorder characterized by deficient activity of arylsulfatase B enzyme (ASB) resulting in cellular accumulation of dermatan sulfate (DS) and chondroitin sulfate (CS) that leads to cell injury. Urinary glycosaminoglycans (GAG) are often used as a biomarker in MPS diseases for diagnosis and to monitor treatment efficacy. This study evaluated leukocyte GAGs (leukoGAG) and skin GAGs as alternate biomarkers representing intracellular GAG changes in patients with MPS VI and treated with enzyme replacement therapy (ERT). In addition, we evaluated corneal opacification measurements (COM) and carotid intima media thickness (CIMT) as indicators of GAG accumulation and tissue injury. The study was performed in a serial two-step design in a single center. A quantitative method to measure leukoGAG levels in leukocytes was developed in Study 1 to compare the GAG levels between MPS VI patients and a control group and to assess correlations between leukoGAG and urineGAG. Study 2 validated the leukoGAG measurement, assessed the effect of ERT infusion on leukoGAG and ASB activity in leukocytes, identified correlations between leukoGAG and other biomarkers, and assessed differences in GAG accumulation between MPS VI patients and control subjects. In Study 1, leukoCS and leukoDS levels were significantly higher in the MPS VI group than the control group (leukoCS: 37.9 ± 10.2 and 2.9 ± 1.5 μg/μg protein, respectively, p = 0.005; leukoDS: 0.26 ± 0.2 and 0.0 ± 0.0 μg/μg protein, respectively, p = 0.028) with positive correlations between leukoCS and urine CS and leukoDS and urineDS. In Study 2, leukoCS (32.0 ± 11.8 vs 6.9 ± 3.1 μg/mg protein, p = 0.005) and leukoDS (0.4 ± 0.1 and 0.2 ± 0.1 μg/mg protein, p = 0.020) were significantly higher compared with control subjects. Thus, these results highlight the potential of leukoGAG as a new biomarker representing intracellular GAG accumulation in MPS VI patients and may be valuable for patient management.-
dc.language.isoen-
dc.titleBiomarkers of Glycosaminoglycans (GAG) accumulation in patients with mucopolysaccharidosis type VI—LeukoGAG, Corneal Opacification (COM) and Carotid Intima Media Thickening (CIMT)-
dc.typeArticle-
dc.identifier.pmid38234862-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10792263-
dc.subject.keywordCarotid intima media thickness-
dc.subject.keywordCorneal opacification measurements-
dc.subject.keywordLeukocyte GAG-
dc.subject.keywordMucopolysaccharidosis type VI-
dc.subject.keywordSkin GAG-
dc.contributor.affiliatedAuthorSohn, YB-
dc.type.localJournal Papers-
dc.identifier.doi10.1016/j.ymgmr.2023.101041-
dc.citation.titleMolecular genetics and metabolism reports-
dc.citation.volume38-
dc.citation.date2024-
dc.citation.startPage101041-
dc.citation.endPage101041-
dc.identifier.bibliographicCitationMolecular genetics and metabolism reports, 38. : 101041-101041, 2024-
dc.identifier.eissn2214-4269-
dc.relation.journalidJ022144269-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Medical Genetics
Files in This Item:
38234862.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse